This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsProbiotec（PBP）株式概要プロバイオテック社は、オーストラリア国内および海外で、医療用医薬品、一般用医薬品、補完医薬品、消費者向け健康食品、日用消費財の開発、製造、包装、流通、販売に従事している。 詳細PBP ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長1/6過去の実績2/6財務の健全性4/6配当金1/6報酬当社が推定した公正価値より48.4%で取引されている 収益は年間6.67%増加すると予測されています リスク分析利益率(3.9%)は昨年より低い(7.2%) すべてのリスクチェックを見るPBP Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueAU$Current PriceAU$2.983.2% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1m306m2016201920222025202620282031Revenue AU$305.5mEarnings AU$12.0mAdvancedSet Fair ValueView all narrativesProbiotec Limited 競合他社Vita Life SciencesSymbol: ASX:VLSMarket cap: AU$139.1mVitura HealthSymbol: ASX:VITMarket cap: AU$23.2mECS Botanics HoldingsSymbol: ASX:ECSMarket cap: AU$8.0mNeuren PharmaceuticalsSymbol: ASX:NEUMarket cap: AU$1.7b価格と性能株価の高値、安値、推移の概要Probiotec過去の株価現在の株価AU$2.9852週高値AU$3.0352週安値AU$2.14ベータ0.471ヶ月の変化2.05%3ヶ月変化6.81%1年変化11.61%3年間の変化39.91%5年間の変化91.03%IPOからの変化158.01%最新ニュースお知らせ • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$2.91, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).Price Target Changed • Nov 17Price target decreased by 7.4% to AU$3.15Down from AU$3.40, the current price target is provided by 1 analyst. New target price is 30% above last closing price of AU$2.42. Stock is up 12% over the past year. The company posted earnings per share of AU$0.14 last year.最新情報をもっと見るRecent updatesお知らせ • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$2.91, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).Price Target Changed • Nov 17Price target decreased by 7.4% to AU$3.15Down from AU$3.40, the current price target is provided by 1 analyst. New target price is 30% above last closing price of AU$2.42. Stock is up 12% over the past year. The company posted earnings per share of AU$0.14 last year.お知らせ • Oct 13Probiotec Limited, Annual General Meeting, Nov 15, 2023Probiotec Limited, Annual General Meeting, Nov 15, 2023, at 11:00 E. Australia Standard Time. Location: Morgans, Level 25, 367 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2023; to consider and, if thought fit, pass the following non-binding ordinary resolution: That the Remuneration Report for the year ended 30 June 2023 be adopted; and to consider other matters.Reported Earnings • Aug 26Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 16%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 25Probiotec Limited Declares Fully Franked Final Dividend for the Period of Six Months Ended June 30, 2023 , Payable on 8 September 2023Probiotec Limited declared a Fully Franked final dividend for the period of six months ended June 30, 2023 of 3.5 cents per ordinary share, fully franked, and to be paid on 8 September 2023. The dividend will be payable to shareholders of record on 1 September 2023. The October 31, 2023.Major Estimate Revision • Mar 02Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$205.0m to AU$214.3m. EPS estimate fell from AU$0.182 to AU$0.159 per share. Net income forecast to shrink 9.8% next year vs 20% growth forecast for Pharmaceuticals industry in Australia . Consensus price target up from AU$3.27 to AU$3.40. Share price was steady at AU$2.35 over the past week.分析記事 • Feb 26Probiotec (ASX:PBP) Is Increasing Its Dividend To A$0.03The board of Probiotec Limited ( ASX:PBP ) has announced that the dividend on 17th of March will be increased to...Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 28Probiotec Limited, Annual General Meeting, Nov 28, 2022Probiotec Limited, Annual General Meeting, Nov 28, 2022, at 11:01 AUS Eastern Standard Time. Location: Arnold Bloch Leibler Level 21, 333 Collins Street Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2022; to adoption of remuneration report; to re-election of director; to approval of executive option plan; issue of performance rights to the chief executive officer; to amendments to the constitution; to renewal of proportional takeover provisions.Recent Insider Transactions • Oct 19Chairman of the Board recently bought AU$97k worth of stockOn the 14th of October, Jonathan Wenig bought around 45k shares on-market at roughly AU$2.16 per share. This transaction amounted to 64% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Jonathan's only on-market trade for the last 12 months.お知らせ • Oct 17Probiotec Limited Announces Resignation of Paul Santoro as Non-Executive DirectorProbiotec Limited advised that Mr. Paul Santoro has submitted his resignation as a Non-Executive Director, effective as of October 17, 2022. Mr. Santoro has advised that due to his full-time commitments as CEO of Cygnett and business interests outside of his role with the Company he can no longer commit the necessary time to continue as a Non-Executive Director of the Company.Upcoming Dividend • Aug 31Upcoming dividend of AU$0.035 per shareEligible shareholders must have bought the stock before 07 September 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of Australian dividend payers (6.6%). In line with average of industry peers (2.5%).Reported Earnings • Aug 24Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Over the next year, revenue is forecast to grow 3.0%, compared to a 147% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 24Probiotec Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2022, Payable on September 15, 2022Probiotec Limited announced ordinary fully paid dividend of AUD 0.03500000 for the twelve months ended June 30, 2022. Record date is September 8, 2022. Ex-date is September 7, 2022. The dividend will be payable on September 15. 2022.お知らせ • Aug 17Probiotec Limited to Report Fiscal Year 2022 Results on Aug 24, 2022Probiotec Limited announced that they will report fiscal year 2022 results on Aug 24, 2022Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Simon Gray was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 09Independent Non-Executive Director recently bought AU$54k worth of stockOn the 7th of March, Simon Gray bought around 25k shares on-market at roughly AU$2.17 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Major Estimate Revision • Mar 03Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from AU$0.17 to AU$0.14 per share. Revenue forecast steady at AU$176.3m. Net income forecast to grow 66% next year vs 21% growth forecast for Pharmaceuticals industry in Australia. Consensus price target up from AU$2.90 to AU$3.04. Share price was steady at AU$2.23 over the past week.Reported Earnings • Feb 28First half 2022 earnings: EPS misses analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 12%, compared to a 358% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.分析記事 • Feb 28Probiotec (ASX:PBP) Has Affirmed Its Dividend Of AU$0.02Probiotec Limited's ( ASX:PBP ) investors are due to receive a payment of AU$0.02 per share on 18th of March. This...お知らせ • Feb 26+ 1 more updateProbiotec Limited Provides Earnings Guidance for the Full Year 2022Probiotec Limited provided earnings guidance for the full year 2022. Based on no worsening of Covid-19 and/or economic conditions, the board expects to deliver revenue of between $175 million and $180 million.お知らせ • Jan 29Probiotec Limited Appoints Paul Santoro as Non-Executive DirectorProbiotec Limited announced that it has appointed Paul Santoro FCPA as a non-executive director of the company. Mr. Santoro is the CEO of Cygnett, a Melbourne-based leading global digital accessories business that designs and manufactures market-leading products including wireless chargers, portable power stations, cables, stands and holders that are sold into 42 countries around the world with offices in the UK, USA and China. He is also co-owner of Forest Hill Medical Centre and co-owner of Universal Business Services, a boutique book-keeping and business advisory company. Mr. Santoro is a FCPA and has a bachelor's degree in Business. Mr. Santoro will join the board under a casual vacancy from 1 February 2022 and be eligible for re-election at the next Annual General Meeting.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.株主還元PBPAU PharmaceuticalsAU 市場7D0%1.2%0.08%1Y11.6%-12.0%3.1%株主還元を見る業界別リターン: PBP過去 1 年間で-12 % の収益を上げたAustralian Pharmaceuticals業界を下回りました。リターン対市場: PBP過去 1 年間で3.1 % の収益を上げたAustralian市場を上回りました。価格変動Is PBP's price volatile compared to industry and market?PBP volatilityPBP Average Weekly Movement1.8%Pharmaceuticals Industry Average Movement10.4%Market Average Movement10.5%10% most volatile stocks in AU Market17.5%10% least volatile stocks in AU Market4.3%安定した株価: PBP 、 Australian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: PBPの 週次ボラティリティ ( 2% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1996n/aWes Stringerwww.probiotec.com.auProbiotec社は、オーストラリア国内および海外で、医療用医薬品、一般用医薬品、補完医薬品、消費者向け健康食品、日用消費財の開発、製造、包装、流通、販売を行っている。固形錠剤、カプセル剤、カプレット剤、錠剤コーティング剤、ブリスターパック、ボトル、小袋、チューブ、液剤、クリーム、ジェル、ローション、軟膏剤、粉末剤、粉末混合剤の受託製造サービスを提供している。また、分析および安定性試験サービス、新製品の処方および製造試験、継続的な研究開発サービス、ヒトおよび動物用栄養製品のパッケージング・オプションも手がけており、さまざまな栄養補助食品や機能性成分原料の製造・輸出も行っている。同社は1996年に法人化され、オーストラリアのラバートン・ノースに本社を置いている。もっと見るProbiotec Limited 基礎のまとめProbiotec の収益と売上を時価総額と比較するとどうか。PBP 基礎統計学時価総額AU$242.34m収益（TTM）AU$8.69m売上高(TTM)AU$221.22m27.9xPER（株価収益率1.1xP/SレシオPBP は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計PBP 損益計算書（TTM）収益AU$221.22m売上原価AU$154.96m売上総利益AU$66.25mその他の費用AU$57.57m収益AU$8.69m直近の収益報告Dec 31, 2023次回決算日該当なし一株当たり利益（EPS）0.11グロス・マージン29.95%純利益率3.93%有利子負債／自己資本比率52.5%PBP の長期的なパフォーマンスは？過去の実績と比較を見る配当金2.2%現在の配当利回り65%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/06/18 17:20終値2024/06/18 00:00収益2023/12/31年間収益2023/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Probiotec Limited 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Andrew TangMorgans Financial LimitedJames FiliusMorgans Financial LimitedJames FiliusMorgans Financial Limited4 その他のアナリストを表示
お知らせ • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.
Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$2.91, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.
New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).
Price Target Changed • Nov 17Price target decreased by 7.4% to AU$3.15Down from AU$3.40, the current price target is provided by 1 analyst. New target price is 30% above last closing price of AU$2.42. Stock is up 12% over the past year. The company posted earnings per share of AU$0.14 last year.
お知らせ • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.
Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to AU$2.91, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.
New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).
Price Target Changed • Nov 17Price target decreased by 7.4% to AU$3.15Down from AU$3.40, the current price target is provided by 1 analyst. New target price is 30% above last closing price of AU$2.42. Stock is up 12% over the past year. The company posted earnings per share of AU$0.14 last year.
お知らせ • Oct 13Probiotec Limited, Annual General Meeting, Nov 15, 2023Probiotec Limited, Annual General Meeting, Nov 15, 2023, at 11:00 E. Australia Standard Time. Location: Morgans, Level 25, 367 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2023; to consider and, if thought fit, pass the following non-binding ordinary resolution: That the Remuneration Report for the year ended 30 June 2023 be adopted; and to consider other matters.
Reported Earnings • Aug 26Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 16%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 25Probiotec Limited Declares Fully Franked Final Dividend for the Period of Six Months Ended June 30, 2023 , Payable on 8 September 2023Probiotec Limited declared a Fully Franked final dividend for the period of six months ended June 30, 2023 of 3.5 cents per ordinary share, fully franked, and to be paid on 8 September 2023. The dividend will be payable to shareholders of record on 1 September 2023. The October 31, 2023.
Major Estimate Revision • Mar 02Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$205.0m to AU$214.3m. EPS estimate fell from AU$0.182 to AU$0.159 per share. Net income forecast to shrink 9.8% next year vs 20% growth forecast for Pharmaceuticals industry in Australia . Consensus price target up from AU$3.27 to AU$3.40. Share price was steady at AU$2.35 over the past week.
分析記事 • Feb 26Probiotec (ASX:PBP) Is Increasing Its Dividend To A$0.03The board of Probiotec Limited ( ASX:PBP ) has announced that the dividend on 17th of March will be increased to...
Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 28Probiotec Limited, Annual General Meeting, Nov 28, 2022Probiotec Limited, Annual General Meeting, Nov 28, 2022, at 11:01 AUS Eastern Standard Time. Location: Arnold Bloch Leibler Level 21, 333 Collins Street Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2022; to adoption of remuneration report; to re-election of director; to approval of executive option plan; issue of performance rights to the chief executive officer; to amendments to the constitution; to renewal of proportional takeover provisions.
Recent Insider Transactions • Oct 19Chairman of the Board recently bought AU$97k worth of stockOn the 14th of October, Jonathan Wenig bought around 45k shares on-market at roughly AU$2.16 per share. This transaction amounted to 64% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Jonathan's only on-market trade for the last 12 months.
お知らせ • Oct 17Probiotec Limited Announces Resignation of Paul Santoro as Non-Executive DirectorProbiotec Limited advised that Mr. Paul Santoro has submitted his resignation as a Non-Executive Director, effective as of October 17, 2022. Mr. Santoro has advised that due to his full-time commitments as CEO of Cygnett and business interests outside of his role with the Company he can no longer commit the necessary time to continue as a Non-Executive Director of the Company.
Upcoming Dividend • Aug 31Upcoming dividend of AU$0.035 per shareEligible shareholders must have bought the stock before 07 September 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 2.5%. Lower than top quartile of Australian dividend payers (6.6%). In line with average of industry peers (2.5%).
Reported Earnings • Aug 24Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Over the next year, revenue is forecast to grow 3.0%, compared to a 147% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 24Probiotec Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2022, Payable on September 15, 2022Probiotec Limited announced ordinary fully paid dividend of AUD 0.03500000 for the twelve months ended June 30, 2022. Record date is September 8, 2022. Ex-date is September 7, 2022. The dividend will be payable on September 15. 2022.
お知らせ • Aug 17Probiotec Limited to Report Fiscal Year 2022 Results on Aug 24, 2022Probiotec Limited announced that they will report fiscal year 2022 results on Aug 24, 2022
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Simon Gray was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 09Independent Non-Executive Director recently bought AU$54k worth of stockOn the 7th of March, Simon Gray bought around 25k shares on-market at roughly AU$2.17 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Major Estimate Revision • Mar 03Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from AU$0.17 to AU$0.14 per share. Revenue forecast steady at AU$176.3m. Net income forecast to grow 66% next year vs 21% growth forecast for Pharmaceuticals industry in Australia. Consensus price target up from AU$2.90 to AU$3.04. Share price was steady at AU$2.23 over the past week.
Reported Earnings • Feb 28First half 2022 earnings: EPS misses analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 1.7%. Over the next year, revenue is forecast to grow 12%, compared to a 358% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.
分析記事 • Feb 28Probiotec (ASX:PBP) Has Affirmed Its Dividend Of AU$0.02Probiotec Limited's ( ASX:PBP ) investors are due to receive a payment of AU$0.02 per share on 18th of March. This...
お知らせ • Feb 26+ 1 more updateProbiotec Limited Provides Earnings Guidance for the Full Year 2022Probiotec Limited provided earnings guidance for the full year 2022. Based on no worsening of Covid-19 and/or economic conditions, the board expects to deliver revenue of between $175 million and $180 million.
お知らせ • Jan 29Probiotec Limited Appoints Paul Santoro as Non-Executive DirectorProbiotec Limited announced that it has appointed Paul Santoro FCPA as a non-executive director of the company. Mr. Santoro is the CEO of Cygnett, a Melbourne-based leading global digital accessories business that designs and manufactures market-leading products including wireless chargers, portable power stations, cables, stands and holders that are sold into 42 countries around the world with offices in the UK, USA and China. He is also co-owner of Forest Hill Medical Centre and co-owner of Universal Business Services, a boutique book-keeping and business advisory company. Mr. Santoro is a FCPA and has a bachelor's degree in Business. Mr. Santoro will join the board under a casual vacancy from 1 February 2022 and be eligible for re-election at the next Annual General Meeting.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$250k worth at the time). A total of 2 executives have left over the last 12 months.
